Flubrotizolam presents itself as a novel benzodiazepine derivative. Introduced for clinical purposes, flubrotizolam possesses intense hypnotic effects. Its chemical properties demonstrate a high affinity for the GABA receptor, producing significant CNS modulation. Although its potential medicinal applications, flubrotizolam's unregulated use has in